BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34177574)

  • 1. Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects.
    Nawa H; Niimura T; Hamano H; Yagi K; Goda M; Zamami Y; Ishizawa K
    Front Pharmacol; 2021; 12():655605. PubMed ID: 34177574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of adverse event of interstitial lung disease in men with prostate cancer receiving hormone therapy using the Food and Drug Administration Adverse Event Reporting System.
    Wu B; Shen P; Yin X; Yu L; Wu F; Chen C; Li J; Xu T
    Br J Clin Pharmacol; 2023 Feb; 89(2):440-448. PubMed ID: 35349180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects.
    Nawa H; Hamano H; Niimura T; Miyata K; Yagi K; Goda M; Zamami Y; Ishizawa K
    Clin Transl Sci; 2022 Dec; 15(12):2982-2988. PubMed ID: 36128688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of potential complication of interstitial lung disease with abemaciclib and palbociclib treatments.
    Nawa H; Niimura T; Yagi K; Goda M; Zamami Y; Ishizawa K
    Cancer Rep (Hoboken); 2022 Jan; 5(1):e1402. PubMed ID: 33939324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
    Nagai J; Ishikawa Y
    PLoS One; 2021; 16(12):e0260980. PubMed ID: 34855908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
    Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Matsumoto K; Tanaka M; Uranishi H; Masuta M; Nishida S; Shimizu S; Hayashi Y; Suzuki A; Nakamura M
    Cancer Chemother Pharmacol; 2019 Nov; 84(5):1097-1105. PubMed ID: 31502115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Expression Time of Ganciclovir-Induced Adverse Events Using JADER and FAERS.
    Ando G; Taguchi K; Enoki Y; Yokoyama Y; Kizu J; Matsumoto K
    Biol Pharm Bull; 2019; 42(11):1799-1804. PubMed ID: 31685764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Clinical Factors in Olaparib-related Anemia Using Adverse Drug Event Reporting Databases.
    Shiraishi C; Hirai T; Ogura T; Iwamoto T
    Anticancer Res; 2023 Feb; 43(2):883-891. PubMed ID: 36697083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin-dependent kinase 4/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment.
    Raschi E; Fusaroli M; Ardizzoni A; Poluzzi E; De Ponti F
    Breast Cancer Res Treat; 2021 Feb; 186(1):219-227. PubMed ID: 33150548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of pregabalin-induced adverse events related to falls using the FDA adverse event reporting system and Japanese Adverse Drug Event Report databases.
    Mukai R; Hasegawa S; Umetsu R; Nakao S; Shimada K; Uranishi H; Masuta M; Suzuki H; Nishibata Y; Nakamura M
    J Clin Pharm Ther; 2019 Apr; 44(2):285-291. PubMed ID: 30569470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADER.
    Yamaoka K; Fujiwara M; Uchida M; Uesawa Y; Shimizu T
    In Vivo; 2023; 37(1):345-356. PubMed ID: 36593055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER) database.
    Shimada K; Hasegawa S; Nakao S; Mukai R; Sasaoka S; Ueda N; Kato Y; Abe J; Mori T; Yoshimura T; Kinosada Y; Nakamura M
    Int J Med Sci; 2019; 16(9):1295-1303. PubMed ID: 31588196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
    Chisaki Y; Aoji S; Yano Y
    Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Appendicitis Cases in the Japanese Adverse Drug Event Report (JADER) Database.
    Kyotani Y; Zhao J; Nakahira K; Yoshizumi M
    Biol Pharm Bull; 2023; 46(5):655-660. PubMed ID: 37121692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Concomitant Usage of Analgesics on Immune Checkpoint Inhibitor-related Interstitial Lung Disease.
    Manabe T; Iwayama K; Chuma M; Tasaki Y; Matsumoto S
    In Vivo; 2023; 37(3):1260-1265. PubMed ID: 37103090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse event reports in patients taking psychiatric medication during pregnancy from spontaneous reports in Japan and the United States: an approach using latent class analysis.
    Anzai T; Takahashi K; Watanabe M; Mochizuki M; Murashima A
    BMC Psychiatry; 2020 Mar; 20(1):118. PubMed ID: 32164630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypharmacy in three different spontaneous adverse drug event databases.
    Mabuchi T; Hosomi K; Yokoyama S; Takada M
    Int J Clin Pharmacol Ther; 2020 Nov; 58(11):601-607. PubMed ID: 32729825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Pressure Elevation Associated with Topical Prostaglandin F2α Analogs: An Analysis of the Different Spontaneous Adverse Event Report Databases.
    Ohyama K; Kawakami H; Inoue M
    Biol Pharm Bull; 2017; 40(5):616-620. PubMed ID: 28458346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.